ATGE
Adtalem Global Education Inc
$
95.140
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
100.300
Open
98.190
VWAP
96.12
Vol
791.75K
Mkt Cap
3.46B
Low
94.930
Amount
76.11M
EV/EBITDA(TTM)
9.40
Total Shares
37.61M
EV
3.83B
EV/OCF(TTM)
10.22
P/S(TTM)
2.01
Adtalem Global Education Inc. is a provider of healthcare education in the United States, preparing a diverse workforce with academic programs. Its healthcare programs include nursing, medicine, veterinary medicine, social and behavioral sciences and more. Its segments include Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and certificate programs in the nursing and health professions postsecondary education industry. Walden segment offers degree and certificate programs, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and certificate programs in the medical and veterinary postsecondary education industry. This segment includes American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q4
FY2026Q3
FY2026Q2
485.06M
+6.12%
1.843
+10.99%
488.96M
+4.91%
2.047
+6.64%
488.72M
+9.15%
2.172
+20.03%
Estimates Revision
The market is revising Upward the revenue expectations for Adtalem Global Education Inc. (ATGE) for FY2026, with the revenue forecasts being adjusted by 1.29% over the past three months. During the same period, the stock price has changed by -20.60%.
Revenue Estimates for FY2026
Revise Upward
+1.29%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
+2.48%
In Past 3 Month
Stock Price
Go Down
-20.60%
In Past 3 Month
3 Analyst Rating
Wall Street analysts forecast ATGE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATGE is 168.33 USD with a low forecast of 163.00 USD and a high forecast of 172.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 95.140
Low
163.00
Averages
168.33
High
172.00
Current: 95.140
Low
163.00
Averages
168.33
High
172.00
Baird
Outperform -> NULL
downgrade
$169 -> $163
2025-10-31
Reason
Baird
Price Target
$169 -> $163
2025-10-31
downgrade
Outperform -> NULL
Reason
Baird lowered the firm's price target on Adtalem Global Education to $163 from $169 and keeps an Outperform rating on the shares. The firm updated its model following Q3 results which saw guidance held despite execution missteps pressuring Chamberlain post licensure.
Barrington
NULL
to
Outperform
maintain
$150 -> $170
2025-10-15
Reason
Barrington
Price Target
$150 -> $170
2025-10-15
maintain
NULL
to
Outperform
Reason
Barrington raised the firm's price target on Adtalem Global Education to $170 from $150 and keeps an Outperform rating on the shares ahead of the fiscal Q1 report on October 30. Demand for healthcare professionals, which represents 90% of Adtalem's enrollment, will continue to outpace supply for the foreseeable future, the analyst tells investors in a research note.
Barrington
Alexander Paris
Outperform
maintain
$140 -> $150
2025-08-08
Reason
Barrington
Alexander Paris
Price Target
$140 -> $150
2025-08-08
maintain
Outperform
Reason
Barrington analyst Alexander Paris raised the firm's price target on Adtalem Global Education to $150 from $140 and keeps an Outperform rating on the shares after the company reported Q4 results that "significantly topped expectations" and gave initial FY26 guidance that was also "well ahead of the consensus." Given Adtalem's focus on nursing and healthcare, the firm believes shares deserves a premium multiple as it expects demand for healthcare professionals will continue to outpace supply "for the foreseeable future."
Baird
Jeffrey Meuler
Outperform
maintain
$143 -> $169
2025-08-08
Reason
Baird
Jeffrey Meuler
Price Target
$143 -> $169
2025-08-08
maintain
Outperform
Reason
Baird analyst Jeffrey Meuler raised the firm's price target on Adtalem Global Education to $169 from $143 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results and 2026 guidance which was above consensus with strong growth.
BMO Capital
Outperform
maintain
$115 -> $132
2025-05-12
Reason
BMO Capital
Price Target
$115 -> $132
2025-05-12
maintain
Outperform
Reason
BMO Capital raised the firm's price target on Adtalem Global Education to $132 from $115 and keeps an Outperform rating on the shares. The company Q3 results beat expectations amid strong enrollment growth and margin expansion and despite continued growth investments, the analyst tells investors in a research note.
Barrington
Outperform
maintain
$120 -> $140
2025-05-09
Reason
Barrington
Price Target
$120 -> $140
2025-05-09
maintain
Outperform
Reason
Barrington raised the firm's price target on Adtalem Global Education to $140 from $120 and keeps an Outperform rating on the shares. The company's fiscal Q3 significantly topped expectations and its full-year guidance was raised, the analyst tells investors in a research note. The firm expects demand for healthcare professionals will continue to outpace supply for the foreseeable future.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Adtalem Global Education Inc (ATGE.N) is 12.34, compared to its 5-year average forward P/E of 11.27. For a more detailed relative valuation and DCF analysis to assess Adtalem Global Education Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
11.27
Current PE
12.34
Overvalued PE
14.27
Undervalued PE
8.28
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
7.75
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
9.25
Undervalued EV/EBITDA
6.24
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
2.23
Current PS
97.49
Overvalued PS
12.11
Undervalued PS
-7.66
Financials
Annual
Quarterly
FY2026Q1
YoY :
+10.75%
462.29M
Total Revenue
FY2026Q1
YoY :
+19.75%
87.47M
Operating Profit
FY2026Q1
YoY :
+32.04%
61.06M
Net Income after Tax
FY2026Q1
YoY :
+41.53%
1.67
EPS - Diluted
FY2026Q1
YoY :
+44.79%
114.61M
Free Cash Flow
FY2026Q1
YoY :
+2.04%
56.57
Gross Profit Margin - %
FY2026Q1
17.39
FCF Margin - %
FY2026Q1
YoY :
+19.22%
13.21
Net Margin - %
FY2026Q1
YoY :
+31.50%
14.36
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
8.0M
USD
5
6-9
Months
127.2K
USD
1
0-12
Months
1.4M
USD
3
Bought
0-3
2
141.8K
USD
Months
3-6
0
0.0
USD
Months
6-9
1
87.2K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
8.5K
Volume
1
0-12
Months
82.1K
Volume
2
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
900.0
Volume
Months
0-12
2
301.7K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
8.0M
USD
5
6-9
Months
127.2K
USD
1
0-12
Months
1.4M
USD
3
Bought
0-3
2
141.8K
USD
Months
3-6
0
0.0
USD
Months
6-9
1
87.2K
USD
Months
0-12
0
0.0
USD
Months
ATGE News & Events
Events Timeline
2025-11-05 (ET)
2025-11-05
07:25:26
Adtalem confirms FY26 adjusted EPS forecast of $7.60-$7.90, aligning with consensus of $7.81
2025-11-05
07:23:55
Adtalem Global Education speeds up its stock buyback initiative.
2025-10-31 (ET)
2025-10-31
12:00:51
Adtalem Global Education Experiences a 27.8% Decline
Sign Up For More Events
Sign Up For More Events
News
8.0
11-05NewsfilterPinnedAdtalem Expands $150 Million Stock Buyback Initiative
6.0
11-01NASDAQ.COMDaily Upgrade Report for Validea's Joel Greenblatt Strategy - November 1, 2025
7.0
10-31NewsfilterAdtalem Global Education Inc. Under Investigation for Securities Fraud - Reach Out to DJS Law Group to Understand Your Rights – ATGE
Sign Up For More News
People Also Watch
NPO
Enpro Inc
212.700
USD
-6.49%
GFF
Griffon Corp
71.240
USD
-2.90%
SKT
Tanger Inc
33.610
USD
-0.80%
KFY
Korn Ferry
64.980
USD
-2.09%
SHC
Sotera Health Co
16.010
USD
+1.27%
IAC
IAC Inc
33.140
USD
+0.39%
RUM
Rumble Inc
5.890
USD
-4.69%
CXT
Crane NXT Co
61.350
USD
-4.44%
FROG
Jfrog Ltd
47.260
USD
+2.47%
ASO
Academy Sports and Outdoors Inc
46.050
USD
-2.52%
FAQ
What is Adtalem Global Education Inc (ATGE) stock price today?
The current price of ATGE is 95.14 USD — it has decreased -2.41 % in the last trading day.
What is Adtalem Global Education Inc (ATGE)'s business?
What is the price predicton of ATGE Stock?
What is Adtalem Global Education Inc (ATGE)'s revenue for the last quarter?
What is Adtalem Global Education Inc (ATGE)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Adtalem Global Education Inc (ATGE)'s fundamentals?
How many employees does Adtalem Global Education Inc (ATGE). have?